BLRX Dividendi: BioLineRx Ltd. Getiri Analizleri



Kâr Dağıtımı

BLRX Kâr Dağıtımı

BioLineRx Ltd.

$3.1

-7.46%

$-0.25

Kapanışta: May 07, 16:00:00 GMT-4

$3.1

Sonrası Piyasa: May 07, 20:00:00 GMT-4

Genel bakış Tahmin Kazanmak Kâr Dağıtımı Finanslar

Önemli İstatistikler

Önceki Kapanış

$3.35

Açılış fiyatı

$3.29

Günün Aralığı

$3.1 - $3.33

52 haftalık aralık

$2.15 - $7.77

İşlem hacmi

13.5K

Ort.Hacim

18.3K

Dividend yield

EPS (TTM)

0.00

Piyasa Değeri

$13.4M

BioLineRx Ltd. nedir?

BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. The company is headquartered in Modiin, Central(Hamerkaz) and currently employs 24 full-time employees. The company went IPO on 2007-01-30. The firm is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The firm is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.